Literature DB >> 23275621

Chronic Tempol treatment restores pharmacological preconditioning in the senescent rat heart.

Jiang Zhu1, Mario J Rebecchi, Qiang Wang, Peter S A Glass, Peter R Brink, Lixin Liu.   

Abstract

Cardioprotective effects of anesthetic preconditioning and cyclosporine A (CsA) are lost with aging. To extend our previous work and address a possible mechanism underlying age-related differences, we investigated the role of oxidative stress in the aging heart by treating senescent animals with the oxygen free radical scavenger Tempol. Old male Fischer 344 rats (22-24 mo) were randomly assigned to control or Tempol treatment groups for 2 or 4 wk (T×2wk and T×4wk, respectively). Rats received isoflurane 30 min before ischemia-reperfusion injury or CsA just before reperfusion. Myocardial infarction sizes were significantly reduced by isoflurane or CsA in the aged rats treated with Tempol (T×4wk) compared with old control rats. In other experiments, young (4-6 mo) and old rats underwent either chronic Tempol or vehicle treatment, and the levels of myocardial protein oxidative damage, antioxidant enzymes, mitochondrial Ca(2+) uptake, cyclophilin D protein, and mitochondrial permeability transition pore opening times were measured. T×4wk significantly increased MnSOD enzyme activity, GSH-to-GSSH ratios, MnSOD protein level, mitochondrial Ca(2+) uptake capacity, reduced protein nitrotyrosine levels, and normalized cyclophilin D protein expression in the aged rat heart. T×4wk also significantly prolonged mitochondrial permeability transition pore opening times induced by reactive oxygen species in old cardiomyocytes. Our studies demonstrate that 4 wk of Tempol pretreatment restores anesthetic preconditioning and cardioprotection by CsA in the old rat and that this is associated with decreased oxidative stress and improved mitochondrial function. Our results point to a new protective strategy for the ischemic myocardium in the high-risk older population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275621     DOI: 10.1152/ajpheart.00794.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Lymphocytes from intermittent hypoxia-exposed rats increase the apoptotic signals in endothelial cells via oxidative and inflammatory injury in vitro.

Authors:  Hengjuan Guo; Jie Cao; Jinna Li; Xiaoyan Yang; Junnan Jiang; Jing Feng; Shuo Li; Jing Zhang; Baoyuan Chen
Journal:  Sleep Breath       Date:  2015-02-01       Impact factor: 2.816

2.  Preclinical systematic review & meta-analysis of cyclosporine for the treatment of myocardial ischemia-reperfusion injury.

Authors:  Joshua Hefler; Braulio A Marfil-Garza; Sandra Campbell; Darren H Freed; A M James Shapiro
Journal:  Ann Transl Med       Date:  2022-09

3.  Effects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Kangxing Song; Shuxia Wang; Dake Qi
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

4.  Tempol intake improves inflammatory status in aged mice.

Authors:  Mayumi Yamato; Ayumi Ishimatsu; Yuuki Yamanaka; Takara Mine; Kenichi Yamada
Journal:  J Clin Biochem Nutr       Date:  2014-05-24       Impact factor: 3.114

5.  The release of cardioprotective humoral factors after remote ischemic preconditioning in humans is age- and sex-dependent.

Authors:  André Heinen; Friederike Behmenburg; Aykut Aytulun; Maximilian Dierkes; Lea Zerbin; Wolfgang Kaisers; Maximilian Schaefer; Tanja Meyer-Treschan; Susanne Feit; Inge Bauer; Markus W Hollmann; Ragnar Huhn
Journal:  J Transl Med       Date:  2018-04-27       Impact factor: 5.531

Review 6.  Mitochondria and aging: A role for the mitochondrial transition pore?

Authors:  Mathieu Panel; Bijan Ghaleh; Didier Morin
Journal:  Aging Cell       Date:  2018-06-11       Impact factor: 9.304

7.  Effects of Antioxidant Tempol on Systematic Inflammation and Endothelial Apoptosis in Emphysematous Rats Exposed to Intermittent Hypoxia.

Authors:  Haiyan Zhao; Yaping Zhao; Xin Li; Leiqian Xu; Fangxin Jiang; Wanju Hou; Lixia Dong; Jie Cao
Journal:  Yonsei Med J       Date:  2018-11       Impact factor: 2.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.